Raremark Raises £3m in Funding

Raremark, a London-based rare disease patient-data platform, has raised £3 million in funding. The round was led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and existing investor the Cass Entrepreneurship Fund. The company will use the funds to develop its patient-engagement and data-analysis technology, which allows biopharmaceutical companies to identify, engage and learn from patients, accelerating the development of new treatments.

Raremark Secures £3 Million Funding to Advance Rare Disease Research

Raremark is a London, UK-based rare disease patient-data platform that provides a machine-learning tech platform for building research networks of rare disease patients and their families. The company provides biopharmaceutical companies with access to anonymized and aggregated patient data, to reduce the time and cost of clinical development, to raise health literacy and informed participation in medical research, to improve the quality of existing therapies and to find new ones.

A London-based rare disease patient-data platform that provides a machine-learning tech platform for building research networks of rare disease patients and their families.

7 years ago

Raremark Secures £3 Million Funding to Advance Rare Disease Research

ProblemHealthcare

Solution

Covered on